(Q36617448)

15 August 2017

Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis (English)

1 reference

15 August 2017

multivariate statistics

1 reference

Maehara Y

1

1 reference

15 August 2017

Tomoda M

2

1 reference

15 August 2017

Hasuda S

3

1 reference

15 August 2017

Kabashima A

4

1 reference

15 August 2017

Tokunaga E

5

1 reference

15 August 2017

Kakeji Y

6

1 reference

15 August 2017

Sugimachi K

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

79

1 reference

15 August 2017

7-8

1 reference

15 August 2017

1255-1261

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690201

15 August 2017

0 references

cites work

Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Clinical implications of the p53 tumor-suppressor gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Immunohistochemical study of p53 in human lung carcinomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Implications of the p53 tumor-suppressor gene in clinical oncology.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Cancer progression and p53.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

The p53 tumour suppressor gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Prognostic significance of p53 overexpression in gastric and colorectal carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

The relationship of p53 immunostaining to survival in carcinoma of the lung

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Accumulation of p53 protein correlates with a poor prognosis in human lung cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

An experimental study on the toxicity of 2,4,6-trichlorophenyl-4'-nitrophenyl ether (CNP) (author's transl).

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Prognostic value of cyclin E and p53 expression in gastric carcinoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Growth pattern and p53 overexpression in patients with early gastric cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Mutant p53 protein associated with chemosensitivity in breast cancer specimens.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362221

Adequacy of margins of resection in gastrectomy for cancer

20 September 2018

1 reference

12 December 2020

Predictors of lymph node metastasis in early gastric cancer

1 reference

12 December 2020

Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time

1 reference

12 December 2020

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

12 December 2020

Early carcinoma of the stomach

1 reference

12 December 2020

A p53-dependent mouse spindle checkpoint

1 reference

12 December 2020

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

12 December 2020

The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma

1 reference

12 December 2020

Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis

1 reference

12 December 2020

Is p53 an independent prognostic factor in patients with laryngeal carcinoma?

1 reference

12 December 2020

Expression of p53 protein in gastric carcinomas is not independently prognostic

1 reference

12 December 2020

Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 protein expression in nephroblastomas: a predictor of poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

Results of resection of gastric cancer extending to adjacent organs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

A tumour-associated cell-surface glycoprotein accompanying p53 overexpression and higher growth potential for gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 expression and prognosis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 expression in gastric cancer: clinicopathological correlation and prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 protein expression and prognosis in squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

Multifactorial analysis of p53 alteration in human cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53, vessel count, and vascular endothelial growth factor expression in human colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

P53 in tumour pathology: can we trust immunocytochemistry?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

p53 point mutations in primary human gastric carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690201

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690201

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference